(4-Chlorophenyl)(4,4-dihydroxypiperidin-1-yl)methanone, 98%, 1g

5-Methyl-5-(2-methylpropyl)imidazolidine-2,4-dione, 97%, 1g

[4-[[(4-Methylphenyl)amino]-carbonyl]phenyl]boronic acid, 95+%, 250mg

2-Chloro-1,3-thiazole-5-carboxylic acid, 97.0%, 25g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole, 95.0%, 1g

Methyl 2-methyl-6-nitrobenzoate, 95.0%, 25g

5-Chlorosalicylanilide>98.0%(T)5g

(1s)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 97%, 100mg

3-(Oxazol-4-yl)benzonitrile, 250mg

tert-butyl (1R,4R)-5-benzyl-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate, 95.0%, 100mg

N-(2-furylmethyl)-6-methoxy-1,3-benzothiazol-2-amine, 95.0%, 500mg

monoclonal de souris anti-GST-tag, F50-3D12.2, 25 µg

tert-Butyl 4-(3-methyl-4-nitrophenyl)piperazine-1-carboxylate, 95.0%, 5g